It has been shown that one of the ERα isoforms, ERα-36, is particularly expressed in GBM tumor cells and shows expression in 96% of stage III–IV glioma samples, while it is very weakly expressed in stage I glial tumors [49]. The gene discussed is ESR1; the disease is central nervous system cancer.